Financial research concept

Robotic Surgery Instruments and Accessories Revenue

Robotic Surgery Instruments and Accessories Revenue is Intuitive's revenue from procedure-linked instruments and accessories used across its surgical platforms.

By Lee BaileyPublished Sep 23, 2026
Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date
Sep 23, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context
17 connected conceptsPart of the reviewed Robotic Surgery Platform Economics; issuer definitions remain distinct where disclosed.
Company examples
1 reviewed companyRelationships reflect supported examples, not a normalized cross-company KPI ranking.
  1. Procedure volume is the core volume driver
  2. Investor caution
  3. Part of the Robotic Surgery Platform Economics
  4. See It in Company Research
  5. Continue Research

Robotic Surgery Instruments and Accessories Revenue is Intuitive's revenue from instruments and accessories that are consumed, replaced, or otherwise purchased as procedures are performed across its surgical platforms.

Intuitive reported $6.019 billion of instruments and accessories revenue in 2025, up from $5.079 billion in 2024.

Procedure volume is the core volume driver

Instruments and accessories create a recurring monetization stream tied to procedure adoption. Intuitive says da Vinci instruments and accessories generally generate roughly $900 to $3,700 of revenue per procedure depending on procedure type and complexity, so procedure mix can matter alongside procedure count.

Investor caution

This revenue category is broader than a simple da Vinci procedure count multiplied by one per-procedure amount. Product mix, procedure complexity, pricing, and revenue from other platforms can affect the relationship.

Source:

Part of the Robotic Surgery Platform Economics

Connect procedure demand, installed-base growth and utilization, system placements and financing mix, and recurring instruments, service, and lease revenue to understand robotic-surgery platform economics.

How the model fits together
  • Procedure demand and installed-base utilization: Annual procedure volume is driven by the system base available through the year and procedures performed per system. Installed-base growth and utilization growth therefore help separate capacity expansion from deeper use, but the point-in-time installed base and annual procedure count do not form an exact accounting identity.
  • Placements, financing mix, and system revenue timing: System placements add customer capacity through sales and multiple lease structures. Operating-lease placement mix changes when revenue is recognized, so placement growth and systems-revenue growth can diverge because of financing mix, product mix, trade-ins, lease buyouts, and pricing.
  • Recurring installed-base monetization: Intuitive defines recurring revenue as instruments and accessories revenue plus service revenue plus operating lease revenue. Procedure activity drives consumable demand, the installed base supports service economics, and leased systems add recurring system revenue, while the recurring-revenue mix shows the combined contribution relative to total company revenue.

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare medical device stocks

Continue into stock comparison for installed-base growth, procedure utilization, recurring revenue, and system-financing economics.

Continue research

Explore more topics in the Financial Research Encyclopedia.